These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 17474075)

  • 1. The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options.
    Agnelli G; Caprini JA
    J Surg Oncol; 2007 Sep; 96(3):265-72. PubMed ID: 17474075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts for the prevention of venous thromboembolism.
    Bramlage P; Pittrow D; Kirch W
    Eur J Clin Invest; 2005 Mar; 35 Suppl 1():4-11. PubMed ID: 15701142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged thromboprophylaxis with low molecular weight heparin after major abdominal surgery.
    Rasmussen MS
    Curr Opin Pulm Med; 2007 Sep; 13(5):389-92. PubMed ID: 17940482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fondaparinux: a new synthetic and selective inhibitor of Factor Xa.
    Bauer KA
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):89-104. PubMed ID: 15171960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of venous thromboembolism in surgery, in laparoscopic surgery, in venous surgery and in urology].
    Gumulec J; Penka M; Bezdĕk R; Czudek S; Stursa M; Wróbel M; Brejcha M; Klodová D; Sumná E; Králová S
    Vnitr Lek; 2006 Mar; 52 Suppl 1():41-50. PubMed ID: 16637449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.
    Agnelli G; Bergqvist D; Cohen AT; Gallus AS; Gent M;
    Br J Surg; 2005 Oct; 92(10):1212-20. PubMed ID: 16175516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
    Burris HA
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy with low molecular weight heparin in cancer patients.
    Petralia P; Kakkar AK
    Eur J Med Res; 2004 Mar; 9(3):119-24. PubMed ID: 15096321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis.
    Bergqvist D
    J Surg Oncol; 2007 Feb; 95(2):167-74. PubMed ID: 17262765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentasaccharides. The new anticoagulants.
    Abdel-Razeq H
    Saudi Med J; 2004 Aug; 25(8):983-90. PubMed ID: 15322584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of venous thromboembolism in surgical patients.
    Agnelli G
    Circulation; 2004 Dec; 110(24 Suppl 1):IV4-12. PubMed ID: 15598646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
    Nutescu EA; Wittkowsky AK; Dobesh PP; Hawkins DW; Dager WE
    Ann Pharmacother; 2006 Sep; 40(9):1558-71. PubMed ID: 16912250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of venous thromboembolism in surgical patients with breast cancer.
    Patiar S; Kirwan CC; McDowell G; Bundred NJ; McCollum CN; Byrne GJ
    Br J Surg; 2007 Apr; 94(4):412-20. PubMed ID: 17380560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated venous thrombosis in the surgical setting.
    Behranwala KA; Williamson RC
    Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential compression devices as prophylaxis for venous thromboembolism in high-risk colorectal surgery patients: reconsidering American Society of Colorectal Surgeons parameters.
    Ramirez JI; Vassiliu P; Gonzalez-Ruiz C; Vukasin P; Ortega A; Kaiser AM; Beart RW
    Am Surg; 2003 Nov; 69(11):941-5. PubMed ID: 14627252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients.
    Bergqvist D
    Dis Colon Rectum; 2006 Oct; 49(10):1620-8. PubMed ID: 17019655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist.
    Bauer KA; Eriksson BI; Lassen MR; Turpie AG
    J South Orthop Assoc; 2002; 11(4):197-202. PubMed ID: 12597063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL).
    Kalka C; Spirk D; Siebenrock KA; Metzger U; Tuor P; Sterzing D; Oehy K; Wondberg D; Mouhsine el Y; Gautier E; Kucher N
    Thromb Haemost; 2009 Jul; 102(1):56-61. PubMed ID: 19572068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
    Lee AY
    Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.